tiprankstipranks
Ember Therapeutics Inc (EMBT)
OTHER OTC:EMBT
US Market

Ember Therapeutics (EMBT) Financial Statements

Compare
4 Followers

Ember Therapeutics Financial Overview

Ember Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Ember Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 14Dec 13Dec 12
Income Statement
Total Revenue
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -17.42K$ -11.08K$ -7.87K
EBITDA$ -17.42K$ -11.08K$ -7.87K
Net Income$ -23.24K$ -16.33K$ -12.79K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―
Total Assets$ 184.00$ 1.25K$ 2.34K
Total Debt$ 200.62K$ 184.97K$ 163.47K
Net Debt$ 200.43K$ 183.71K$ 161.12K
Total Liabilities$ 238.65K$ 216.48K$ 201.24K
Stockholders' Equity$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -16.72K$ -22.59K$ -4.81K
Operating Cash Flow$ -16.72K$ -22.59K$ -4.81K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Ember Therapeutics Earnings and Revenue History

Ember Therapeutics Debt to Assets

Ember Therapeutics Cash Flow

Ember Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis